Association of Methylenetetrahydrofolate Dehydrogenase 1 Polymorphisms with Cancer: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Zhang, Hongtuan ^a   Ma, Hui ^b   Li, Liang ^a   Zhang, Zhihong ^a   Xu, Yong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARGININE; LYSINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; CANCER RESEARCH; CANCER RISK; COLON CANCER; DISEASE ASSOCIATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ALLELES; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84880403091     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069366     Document Type: Article

References (46)

1. Bredberg A, (2011) Cancer: More of polygenic disease and less of multiple mutations? A quantitative viewpoint. Cancer 117: 440-445.
2. Hoeijmakers JHJ, (2001) Genome maintenance mechanisms for preventing cancer. Nature 411: 366-374.
3. Pharoah PDP, Dunning AM, Ponder BAJ, Easton DF, (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4: 850-860.
4. Wang Y, Guo W, He Y, Chen Z, Wen D, et al. (2007) Association of MTHFR C677T and SHMT1 C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. Cancer Causes Control 18: 143-152.
5. Wang L, Lu J, An J, Shi Q, Spitz MR, et al. (2007) Polymorphisms of cytosolic serine hydroxyl-methyltransferase and risk of lung cancer: a case-control analysis. Lung Cancer 57: 143-151.
6. Ma E, Iwasaki M, Junko I, Hamada GS, Nishimoto IN, et al. (2009) Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMC Cancer 9: 122.
7. Friso S, Choi SW, (2005) Gene-nutrient interactions in one-carbon metabolism. Curr Drug Metab 6: 37-46.
8. Duthie SJ, (1999) Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 55: 578-592.
9. Linhart HG, Troen A, Bell GW, Cantu E, Chao W, et al. (2009) Folate deficiency induces genomic uracil misincorporation and hypomethylation but does not increase DNA point mutations. Gastroenterology 136: 227-235.
10. Hum DW, Bell AW, Rozen R, MacKenzie RE, (1988) Primary structure of a human trifunctional enzyme: isolation of a cDNA encoding methylenetetrahydrofolate-dehydrogenase,methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase. J Biol Chem 263: 15946-15950.
11. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, et al. (2002) A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 71: 1207-1215.
12. Chen LH, Liu ML, Hwang HY, Chen LS, Korenberg J, et al. (1997) Human methionine synthase: cDNA cloning, gene localization, and expression. J Biol Chem 272: 3628-3634.
13. Cantoni GL, (1953) S-Adenosylmethionine; a new intermediate formed enzymatically from L-methionine and adenosinetriphosphate. J Biol Chem 204: 403-416.
14. Parle-McDermott A, Mills JL, Kirke PN, Cox C, Signore CC, et al. (2005) MTHFD1 R653Q polymorphism is a maternal genetic risk factor for severe abruptio placentae. Am J Med Genet A 132: 365-368.
15. Mostowska A, Hozyasz KK, Jagodzinski PP, (2006) Maternal MTR genotype contributes to the risk of non-syndromic cleft lipand palate in the Polish population. Clin Genet 69: 512-517.
16. Charasson V, Hillaire-Buys D, Solassol I, Laurand-Quancard A, Pinguet F, et al. (2009) Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a model. Eur J Cancer 45: 2391-2401.
17. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
18. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
19. Silva LM, Silva JN, Galbiatti AL, Succi M, Ruiz MT, et al. (2011) Head and neck carconogenesis: impact of MTHFD1 G1958A polymorphism. Rev Assoc Med Bras 57: 194-199.
20. Galbiatti AL, da Silva LM, Ruiz-Cintra MT, Raposo LS, Maníglia JV, et al. (2012) Association between 11 genetic polymorphisms in folate-metabolising genes and head and neck cancer risk. Eur J Cancer 48: 1525-1531.
21. da Silva LM, Galbiatti AL, Ruiz MT, Raposo LS, Maniglia JV, et al. (2012) MTHFD1 G1958A, BHMT G742A, TC2 C776G and TC2 A67G polymorphisms and head and neck squamous cell carcinoma risk. Mol Biol Rep 39: 887-893.
22. Liu AY, Scherer D, Poole E, Potter JD, Curtin K, et al. (2012) Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Mol Nutr Food Res doi: 10.1002/mnfr.201200180. [Epub ahead of print].
23. Pawlik P, Mostowska A, Lianeri M, Sajdak S, Ke{ogonek}dzia H, et al. (2012) Folate and choline metabolism gene variants in relation to ovarian cancer risk in the Polish population. Mol Biol Rep 2012 39: 5553-5560.
24. Chan JY, Ugrasena DG, Lum DW, Lu Y, Yeoh AE, (2011) Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children. Hematol Oncol 29: 116-123.
25. Yang L, Liu L, Wang J, Qiu L, Mi Y, et al. (2011) Polymorphisms in folate-related genes: impact on risk of adult acute lymphoblastic leukemia rather than pediatric in Han Chinese. Leuk Lymphoma 52: 1770-1776.
26. Mostowska A, Myka M, Lianeri M, Roszak A, Jagodziński PP, (2011) Folate and choline metabolism gene variants and development of uterine cervical carcinoma. Clin Biochem 44: 596-600.
27. Weiner AS, Beresina OV, Voronina EN, Voropaeva EN, Boyarskih UA, et al. (2011) Polymorphisms in folate-metabolizing genes and risk of non-Hodgkin's lymphoma. Leuk Res 35: 508-515.
28. Kruszyna Ł, Lianeri M, Rydzanicz M, Gajecka M, Szyfter K, et al. (2010) Polymorphic variants of folate metabolism genes and the risk of laryngeal cancer. Mol Biol Rep 37: 241-247.
29. Vaǐner AS, Boiarskikh UA, Voronina EN, Selezneva IA, Sinkina TV, et al. (2010) [Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR, C1420T SHMT1 and G1958A MTHFD) are not associated with the risk of breast cancer in West Siberian Region of Russia]. Mol Biol (Mosk) 44: 816-823.
30. Collin SM, Metcalfe C, Zuccolo L, Lewis SJ, Chen L, et al. (2009) Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 18: 2528-2539.
31. Stevens VL, Rodriguez C, Sun J, Talbot JT, Thun MJ, et al. (2008) No association of single nucleotide polymorphisms in one-carbon metabolism genes with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 17: 3612-3614.
32. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, et al. (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet 38: 652-658.
33. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39: 645-649.
34. Murabito JM, Rosenberg CL, Finger D, Kreger BE, Levy D, et al. (2007) A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study. BMC Med Genet 8Suppl 1: S6.
35. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40: 316-321.
36. Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, et al. (2007) Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 28: 1672-1679.
37. Chen J, Kyte C, Valcin M, Chan W, Wetmur JG, et al. (2004) Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study. Int J Cancer 110: 617-620.
38. Metayer C, Scélo G, Chokkalingam AP, Barcellos LF, Aldrich MC, et al. (2011) Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control 22: 1243-1258.
39. Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM, et al. (2010) Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 19: 1822-1830.
40. Stevens VL, McCullough ML, Pavluck AL, Talbot JT, Feigelson HS, et al. (2007) Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev 16: 1140-1147.
41. Zhang T, Lou J, Zhong R, Wu J, Zou L, et al. (2013) Genetic variants in the folate pathway and the risk of neural tube defects: a meta-Analysis of the published literature. PLoS One 8: e59570.
42. Wang L, Miao X, Tan W, Lu X, Zhao P, et al. (2005) Genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer. Clin Gastroenterol Hepatol 3: 743-751.
43. Wang W, Wang Y, Gong F, Zhu W, Fu S, (2013) MTHFR C677T polymorphism and risk of congenital heart defects: evidence from 29 case-control and TDT studies. PLoS One 8: e58041.
44. Ioannidis JP, (1998) Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 279: 281-286.
45. Dickersin K, Min YI, Meinert CL, (1992) Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. JAMA 267: 374-378.
46. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR, (1991) Publication bias in clinical research. Lancet 337: 867-872.